Management and Follow-up Results of Salivary Fistulas Treated With Botulinum Toxin.
Aged
Botulinum Toxins, Type A
/ administration & dosage
Female
Follow-Up Studies
Humans
Injections
Male
Middle Aged
Neuromuscular Agents
/ administration & dosage
Parotid Diseases
/ surgery
Parotid Gland
/ surgery
Postoperative Complications
/ drug therapy
Retrospective Studies
Salivary Gland Fistula
/ drug therapy
Treatment Outcome
Parotid surgery
botulinum toxin
salivary fistula
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
26
01
2018
revised:
13
05
2018
accepted:
06
06
2018
pubmed:
29
8
2018
medline:
24
5
2019
entrez:
29
8
2018
Statut:
ppublish
Résumé
Salivary fistulas are a common minor complication of parotid surgery. botulinum toxin has repeatedly been reported to be an adequate treatment of this entity. To date, there is little scientific evidence for clinical decision making after appearance of a salivary fistula. Retrospective chart analysis of 16 patients who had been treated with botulinum toxin for salivary fistula. All patients who had been treated for salivary fistula at a tertiary referral hospital from 2010 to 2016 were included. Patient files were used to obtain characteristics of patients, treatment, and follow-up. Sixteen patients with salivary fistula received 27 injections of botulinum toxin. Nine patients required one injection for the fistula to heal, five patients needed two injections, and one patient needed three and four injections, respectively. No patient underwent additional surgery or radiotherapy. We observed no adverse effects in any patient treated with botulinum toxin. In most cases of salivary fistula, injections of botulinum toxin are a valid treatment. If the initial injection is not successful, injections may be repeated once. Otherwise, revision surgery should be considered. In general, treatment with botulinum toxin should be commenced in an earlier stage and with higher dosages. 4 Laryngoscope, 129:403-408, 2019.
Substances chimiques
Neuromuscular Agents
0
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
403-408Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.